TipRanks
Go Ultimate55% OFF

Myriad Genetics (MYD) Ownership - Who Owns Myriad Genetics?

Myriad Genetics (MYD) Ownership Overview

  • 5.82% Insiders
  • 18.29% Mutual Funds
  • 1.16% Other Institutional Investors
  • 16.98% ETFs
  • 57.74% Public Companies and Individual Investors

The ownership structure of Myriad Genetics (DE:MYD) stock is a mix of institutional, retail, and individual investors. Approximately 36.44% of the company’s stock is owned by Institutional Investors, 5.82% is owned by Insiders, and 57.74% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
May 13, 2026Paul Bisaro$27,600
Mar 08, 2026Samraat S. Raha$199,600
Feb 26, 2026Louise Phanstiel$494,487

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Graham Capital Management, L.p.€185,096
Dec 31, 2025Royce & Associates Llc€3,720,750
Dec 31, 2025Fisher Asset Management Llc€7,423,166

Top Shareholders

DE:MYD top shareholders
Holder# of SharesType% HoldingValue
Larry Robbins5,411,978Institution5.66%34,625,835
Vanguard5,112,875Institution5.35%32,712,174
Ishares4,349,353Institution4.55%27,827,160
Vanguard Index Funds3,990,763Institution4.17%25,532,902
Spdr3,336,246Institution3.49%21,345,302
Tiaa-cref Funds1,966,783Institution2.06%12,583,478
Blackrock Funds1,892,092Institution1.98%12,105,605
Vanguard Horizon Funds1,704,409Institution1.78%10,904,809
Ken Fisher1,190,896Institution1.25%7,619,353
Fidelity Salem Street Trust1,152,201Institution1.20%7,371,782

Top Mutual Fund Holders

DE:MYD top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds3,990,763Institution4.17%25,532,902
Tiaa-cref Funds1,966,783Institution2.06%12,583,478
Blackrock Funds1,892,092Institution1.98%12,105,605
Vanguard Horizon Funds1,704,409Institution1.78%10,904,809
Fidelity Salem Street Trust1,152,201Institution1.20%7,371,782
Federated Hermes Mdt Series1,116,258Institution1.17%7,141,819
Fidelity Concord Street Trust891,494Institution0.93%5,703,779
Schwab Capital Trust851,143Institution0.89%5,445,613
Vanguard Scottsdale Funds623,795Institution0.65%3,991,040
Goldman Sachs Trust441,159Institution0.46%2,822,535

FAQ

Who Owns Myriad Genetics (DE:MYD)?
According to the latest TipRanks data, approximately 36.44% of the company's stock is held by institutional investors, 5.82% is held by insiders, and 57.74% is held by public companies and individual investors.
What percentage of Myriad Genetics (DE:MYD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 36.44% of Myriad Genetics (DE:MYD) stock is held by institutional investors: 18.29% by mutual funds, 16.98% by ETFs and 1.16% by other institutional investors.
What percentage of Myriad Genetics (DE:MYD) stock is held by retail investors?
According to the latest TipRanks data, approximately 57.74% of Myriad Genetics (DE:MYD) stock is held by public companies and individual investors.
Who owns the most shares of Myriad Genetics (DE:MYD)?
Larry Robbins owns the most shares of Myriad Genetics (DE:MYD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.